Genome Medicine (Jul 2022)
Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
- Thomas E. Bartlett,
- Iona Evans,
- Allison Jones,
- James E. Barrett,
- Shaun Haran,
- Daniel Reisel,
- Kiriaki Papaikonomou,
- Louise Jones,
- Chiara Herzog,
- Nora Pashayan,
- Bruno M. Simões,
- Robert B. Clarke,
- D. Gareth Evans,
- Talayeh S. Ghezelayagh,
- Sakthivignesh Ponandai-Srinivasan,
- Nageswara R. Boggavarapu,
- Parameswaran G. Lalitkumar,
- Sacha J. Howell,
- Rosa Ana Risques,
- Angelique Flöter Rådestad,
- Louis Dubeau,
- Kristina Gemzell-Danielsson,
- Martin Widschwendter
Affiliations
- Thomas E. Bartlett
- Department of Statistical Science, University College London
- Iona Evans
- Department of Women’s Cancer, UCL EGA Institute for Women’s Health, University College London
- Allison Jones
- Department of Women’s Cancer, UCL EGA Institute for Women’s Health, University College London
- James E. Barrett
- Department of Women’s Cancer, UCL EGA Institute for Women’s Health, University College London
- Shaun Haran
- Department of Women’s Cancer, UCL EGA Institute for Women’s Health, University College London
- Daniel Reisel
- Department of Women’s Cancer, UCL EGA Institute for Women’s Health, University College London
- Kiriaki Papaikonomou
- Department of Women’s and Children’s Health, Division of Obstet- rics and Gynecology, Karolinska Institutet and Karolinska University Hospital
- Louise Jones
- Centre for Tumour Biology Department, Barts Cancer Institute, Queen Mary University of London
- Chiara Herzog
- European Translational Oncology Prevention and Screening (EUTOPS) Institute, Universität Innsbruck
- Nora Pashayan
- Department of Applied Health Research, University College London
- Bruno M. Simões
- Breast Biology Group, Manchester Breast Centre, Divi- sion of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester
- Robert B. Clarke
- Breast Biology Group, Manchester Breast Centre, Divi- sion of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester
- D. Gareth Evans
- University of Manchester, St. Mary’s Hospital, and University Hospital of South Manchester
- Talayeh S. Ghezelayagh
- Department of Laboratory Medicine and Pathology, University of Washing- ton
- Sakthivignesh Ponandai-Srinivasan
- Department of Women’s and Children’s Health, Division of Obstet- rics and Gynecology, Karolinska Institutet and Karolinska University Hospital
- Nageswara R. Boggavarapu
- Department of Women’s and Children’s Health, Division of Obstet- rics and Gynecology, Karolinska Institutet and Karolinska University Hospital
- Parameswaran G. Lalitkumar
- Department of Women’s and Children’s Health, Division of Obstet- rics and Gynecology, Karolinska Institutet and Karolinska University Hospital
- Sacha J. Howell
- Breast Biology Group, Manchester Breast Centre, Divi- sion of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester
- Rosa Ana Risques
- Department of Laboratory Medicine and Pathology, University of Washing- ton
- Angelique Flöter Rådestad
- Department of Women’s and Children’s Health, Division of Obstet- rics and Gynecology, Karolinska Institutet and Karolinska University Hospital
- Louis Dubeau
- Department of Pathology, Keck School of Medicine, USC/Norris Comprehensive Cancer Centre, University of Southern California
- Kristina Gemzell-Danielsson
- Department of Women’s and Children’s Health, Division of Obstet- rics and Gynecology, Karolinska Institutet and Karolinska University Hospital
- Martin Widschwendter
- Department of Women’s Cancer, UCL EGA Institute for Women’s Health, University College London
- DOI
- https://doi.org/10.1186/s13073-022-01086-y
- Journal volume & issue
-
Vol. 14,
no. 1
pp. 1 – 2
Abstract
No abstracts available.
